260 related articles for article (PubMed ID: 33974632)
1. NMDA receptor inhibition increases, synchronizes, and stabilizes the collective pancreatic beta cell activity: Insights through multilayer network analysis.
Šterk M; Križančić Bombek L; Skelin Klemen M; Slak Rupnik M; Marhl M; Stožer A; Gosak M
PLoS Comput Biol; 2021 May; 17(5):e1009002. PubMed ID: 33974632
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the role of N-methyl-D-aspartate (NMDA) receptors in insulin secreting beta-cells.
Patterson S; Irwin N; Guo-Parke H; Moffett RC; Scullion SM; Flatt PR; McClenaghan NH
Eur J Pharmacol; 2016 Jan; 771():107-13. PubMed ID: 26688567
[TBL] [Abstract][Full Text] [Related]
3. Dextromethorphan and Dextrorphan Influence Insulin Secretion by Interacting with K
Gresch A; Düfer M
J Pharmacol Exp Ther; 2020 Oct; 375(1):10-20. PubMed ID: 32665318
[TBL] [Abstract][Full Text] [Related]
4. Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment.
Marquard J; Otter S; Welters A; Stirban A; Fischer A; Eglinger J; Herebian D; Kletke O; Klemen MS; Stožer A; Wnendt S; Piemonti L; Köhler M; Ferrer J; Thorens B; Schliess F; Rupnik MS; Heise T; Berggren PO; Klöcker N; Meissner T; Mayatepek E; Eberhard D; Kragl M; Lammert E
Nat Med; 2015 Apr; 21(4):363-72. PubMed ID: 25774850
[TBL] [Abstract][Full Text] [Related]
5. Acute D-Serine Co-Agonism of β-Cell NMDA Receptors Potentiates Glucose-Stimulated Insulin Secretion and Excitatory β-Cell Membrane Activity.
Lockridge A; Gustafson E; Wong A; Miller RF; Alejandro EU
Cells; 2021 Jan; 10(1):. PubMed ID: 33430405
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition.
Spooren W; Mombereau C; Maco M; Gill R; Kemp JA; Ozmen L; Nakanishi S; Higgins GA
Psychopharmacology (Berl); 2004 Aug; 175(1):99-105. PubMed ID: 14985927
[TBL] [Abstract][Full Text] [Related]
7. Endoplasmic reticulum stress contributes to NMDA-induced pancreatic β-cell dysfunction in a CHOP-dependent manner.
Huang XT; Liu W; Zhou Y; Sun M; Sun CC; Zhang CY; Tang SY
Life Sci; 2019 Sep; 232():116612. PubMed ID: 31260687
[TBL] [Abstract][Full Text] [Related]
8. Functional characteristics of hub and wave-initiator cells in β cell networks.
Šterk M; Dolenšek J; Skelin Klemen M; Križančić Bombek L; Paradiž Leitgeb E; Kerčmar J; Perc M; Slak Rupnik M; Stožer A; Gosak M
Biophys J; 2023 Mar; 122(5):784-801. PubMed ID: 36738106
[TBL] [Abstract][Full Text] [Related]
9. NMDA receptor antagonists inhibit apomorphine-induced climbing behavior not only in intact mice but also in reserpine-treated mice.
Kim HS; Rhee GS; Oh S; Park WK
Behav Brain Res; 1999 Apr; 100(1-2):135-42. PubMed ID: 10212060
[TBL] [Abstract][Full Text] [Related]
10. Need for Better Diabetes Treatment: The Therapeutic Potential of NMDA Receptor Antagonists.
Welters A; Lammert E; Mayatepek E; Meissner T
Klin Padiatr; 2017 Jan; 229(1):14-20. PubMed ID: 27975343
[TBL] [Abstract][Full Text] [Related]
11. NMDA receptors - regulatory function and pathophysiological significance for pancreatic beta cells.
Noguera Hurtado H; Gresch A; Düfer M
Biol Chem; 2023 Mar; 404(4):311-324. PubMed ID: 36626848
[TBL] [Abstract][Full Text] [Related]
12. Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice.
Geter-Douglass B; Witkin JM
Psychopharmacology (Berl); 1997 Sep; 133(1):43-50. PubMed ID: 9335079
[TBL] [Abstract][Full Text] [Related]
13. From Isles of Königsberg to Islets of Langerhans: Examining the Function of the Endocrine Pancreas Through Network Science.
Stožer A; Šterk M; Paradiž Leitgeb E; Markovič R; Skelin Klemen M; Ellis CE; Križančić Bombek L; Dolenšek J; MacDonald PE; Gosak M
Front Endocrinol (Lausanne); 2022; 13():922640. PubMed ID: 35784543
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to MK-801 in phospholipase C-β1 knockout mice reveals a specific NMDA receptor deficit.
Gray L; McOmish CE; Scarr E; Dean B; Hannan AJ
Int J Neuropsychopharmacol; 2009 Aug; 12(7):917-28. PubMed ID: 19236734
[TBL] [Abstract][Full Text] [Related]
15. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function.
Duncan G; Miyamoto S; Gu H; Lieberman J; Koller B; Snouwaert J
Brain Res; 2002 Oct; 951(2):166-76. PubMed ID: 12270494
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by noncompetitive NMDA receptor antagonists of apomorphine-induced climbing behavior in mice.
Kim HS; Rhee GS; Jung JY; Lee JH; Jang CG; Park WK
Life Sci; 1996; 58(17):1397-402. PubMed ID: 8622565
[TBL] [Abstract][Full Text] [Related]
17. NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions.
Welters A; Klüppel C; Mrugala J; Wörmeyer L; Meissner T; Mayatepek E; Heiss C; Eberhard D; Lammert E
Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():95-106. PubMed ID: 28880473
[TBL] [Abstract][Full Text] [Related]
18. Antenatal blockade of N-methyl-D-aspartate receptors by Memantine reduces the susceptibility to diabetes induced by a high-fat diet in rats with intrauterine growth restriction.
Huang XT; Yue SJ; Li C; Guo J; Huang YH; Han JZ; Feng DD; Luo ZQ
Biol Reprod; 2017 May; 96(5):960-970. PubMed ID: 28486599
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of in vivo [(3)H]MK-801 binding by NMDA receptor open channel blockers and GluN2B antagonists in rats and mice.
Fernandes A; Wojcik T; Baireddy P; Pieschl R; Newton A; Tian Y; Hong Y; Bristow L; Li YW
Eur J Pharmacol; 2015 Nov; 766():1-8. PubMed ID: 26325093
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate antagonist activity of alpha- and beta-sulfallorphans.
Shukla VK; Lemaire S
J Pharmacol Exp Ther; 1997 Jan; 280(1):357-65. PubMed ID: 8996216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
